TGF-β overexpression has been clinically observed in various cancers, including malignant melanoma, breast, colon, esophagus, stomach, liver, lung, kidney, pancreas, prostate, and brain (Haque & Morris, 2017). Here, TGFB1 is linked to melanoma.